Study finds more polyarticular JIA patients achieve clinical remission with combined conventional and biologic DMARDs

Close up of chemical microscope and medical research equipment in scientific laboratory. Liquid examination tool with glass lens and blood samples in vacutainers on professional desk

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, demonstrated that polyarticular juvenile idiopathic arthritis patients were more likely to achieve clinical remission with a combination of conventional and biologic DMARDs compared with other consensus treatment plans by the Childhood Arthritis and Rheumatology Research Alliance (CARRA).

Airbnb will finally show you the *actual* total price in search

Previous article

In-House Vs. Outsource Blockchain Development: Which to Prefer?

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations